Marion M. Nau

11.2k total citations · 5 hit papers
75 papers, 9.2k citations indexed

About

Marion M. Nau is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Marion M. Nau has authored 75 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 35 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Marion M. Nau's work include Cancer-related Molecular Pathways (20 papers), RNA modifications and cancer (15 papers) and Glycosylation and Glycoproteins Research (11 papers). Marion M. Nau is often cited by papers focused on Cancer-related Molecular Pathways (20 papers), RNA modifications and cancer (15 papers) and Glycosylation and Glycoproteins Research (11 papers). Marion M. Nau collaborates with scholars based in United States, Ukraine and Chile. Marion M. Nau's co-authors include John D. Minna, Adi F. Gazdar, Desmond N. Carney, Seth A. Ettenberg, Stanley Lipkowitz, Maccon Keane, Stan Lipkowitz, Philip Leder, Michael J. Birrer and J D Minna and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Marion M. Nau

73 papers receiving 8.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p53: A Frequent Target for Genetic Abnormalities in Lung Cancer

1989 1.1k citations Takashi Takahashi, Marion M. Nau et al. profile →
Amplification and expression of the c-myc oncogene in human lung cancer cell lines

1983 775 citations Marion M. Nau, Desmond N. Carney et al. profile →
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

1985 543 citations Marion M. Nau, James F. Battey et al. profile →
Differential expression of myc family genes during murine development

1986 480 citations Marion M. Nau, John D. Minna et al. profile →
Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.

1985 397 citations Adi F. Gazdar, Desmond N. Carney et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marion M. Nau United States	43	6.0k	4.2k	1.7k	1.1k	1.1k	75	9.2k
Sandra H. Bigner United States	48	8.4k 1.4×	3.4k 0.8×	2.2k 1.3×	1.5k 1.3×	1.3k 1.1×	115	13.0k
Albert J. Wong United States	54	6.3k 1.0×	3.8k 0.9×	1.3k 0.8×	1.4k 1.2×	714 0.6×	94	10.5k
Adrian Merlo Switzerland	46	5.8k 1.0×	2.8k 0.7×	1.9k 1.1×	1.1k 1.0×	634 0.6×	89	9.4k
William J. Gullick United Kingdom	60	5.1k 0.8×	6.0k 1.4×	1.1k 0.6×	1.3k 1.2×	850 0.7×	154	10.3k
Jorge Filmus Canada	54	7.8k 1.3×	2.7k 0.6×	2.0k 1.1×	800 0.7×	1.1k 1.0×	103	11.8k
J. William Harbour United States	57	7.0k 1.2×	5.5k 1.3×	1.6k 0.9×	1.3k 1.1×	631 0.6×	198	13.3k
Bruno Calabretta United States	65	8.6k 1.4×	2.6k 0.6×	1.6k 0.9×	455 0.4×	1.1k 0.9×	237	13.2k
Janice Nigro United States	24	5.8k 1.0×	4.5k 1.1×	3.7k 2.1×	1.0k 0.9×	920 0.8×	32	10.6k
Denise Sheer United Kingdom	51	6.0k 1.0×	2.1k 0.5×	1.3k 0.8×	1.6k 1.4×	1.9k 1.7×	178	10.9k
Alan Mackay United Kingdom	56	5.5k 0.9×	3.9k 0.9×	3.5k 2.0×	1.3k 1.1×	1.4k 1.2×	134	10.1k

Countries citing papers authored by Marion M. Nau

Since Specialization

Citations

This map shows the geographic impact of Marion M. Nau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion M. Nau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion M. Nau more than expected).

Fields of papers citing papers by Marion M. Nau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion M. Nau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion M. Nau. The network helps show where Marion M. Nau may publish in the future.

Co-authorship network of co-authors of Marion M. Nau

This figure shows the co-authorship network connecting the top 25 collaborators of Marion M. Nau. A scholar is included among the top collaborators of Marion M. Nau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion M. Nau. Marion M. Nau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kales, Stephen C., et al.. (2019). Loss of function Cbl-c mutations in solid tumors. PLoS ONE. 14(7). e0219143–e0219143. 10 indexed citations

Kales, Stephen C., Marion M. Nau, Anand S. Merchant, & Stanley Lipkowitz. (2014). Enigma Prevents Cbl-c-Mediated Ubiquitination and Degradation of RETMEN2A. PLoS ONE. 9(1). e87116–e87116. 22 indexed citations

Furusato, Bungo, Syed Shaheduzzaman, Vasantha Srikantan, et al.. (2011). Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression. Prostate Cancer and Prostatic Diseases. 15(2). 150–156. 56 indexed citations

Rahman, Monzur, Sean Davis, Janet G. Pumphrey, et al.. (2008). TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Research and Treatment. 113(2). 217–230. 147 indexed citations

Davies, Gareth, et al.. (2004). Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene. 23(42). 7104–7115. 71 indexed citations

Cuello, Mauricio, Seth A. Ettenberg, Amy S. Clark, et al.. (2001). Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.. PubMed. 61(12). 4892–900. 301 indexed citations

Liu, Jianjun, et al.. (2001). Physical interaction between p53 and primary response gene Egr-1. International Journal of Oncology. 18(4). 863–70. 55 indexed citations

Ettenberg, Seth A., Alessandra Magnifico, Mauricio Cuello, et al.. (2001). Cbl-b-dependent Coordinated Degradation of the Epidermal Growth Factor Receptor Signaling Complex. Journal of Biological Chemistry. 276(29). 27677–27684. 125 indexed citations

Keane, Maccon, Yaffa Rubinstein, Mauricio Cuello, et al.. (2000). Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines. Breast Cancer Research and Treatment. 64(2). 211–219. 87 indexed citations

10.

Keane, Maccon, Seth A. Ettenberg, Marion M. Nau, E K Russell, & Stanley Lipkowitz. (1999). Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.. PubMed. 59(3). 734–41. 483 indexed citations

11.

Liu, Jun, Marion M. Nau, Jessica Zucman‐Rossi, et al.. (1997). LINE-I element insertion at the t(11;22) translocation breakpoint of a desmoplastic small round cell tumor. Genes Chromosomes and Cancer. 18(3). 232–239. 35 indexed citations

12.

Brauch, Hiltrud, Tor Knutsen, B. E. Johnson, et al.. (1995). Molecular genetic characterization of neuroendocrine lung cancer cell lines.. PubMed. 15(2). 225–32. 41 indexed citations

13.

Bodner, Sara M., J D Minna, Stig M. R. Jensen, et al.. (1993). Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Lung Cancer. 8(5-6). 334–334. 257 indexed citations

14.

Felix, Carolyn A., D D’Amico, Tetsuya Mitsudomi, et al.. (1992). Absence of hereditary p53 mutations in 10 familial leukemia pedigrees.. Journal of Clinical Investigation. 90(2). 653–658. 34 indexed citations

15.

Felix, Carolyn A., Marion M. Nau, Takashi Takahashi, et al.. (1992). Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.. Journal of Clinical Investigation. 89(2). 640–647. 84 indexed citations

16.

Whang‐Peng, Jacqueline, Tor Knutsen, Adi F. Gazdar, et al.. (1991). Nonrandom structural and numerical chromosome changes in non‐small‐cell lung cancer. Genes Chromosomes and Cancer. 3(3). 168–188. 86 indexed citations

17.

Schütte, J., Jean Viallet, Marion M. Nau, et al.. (1989). jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell. 59(6). 987–997. 429 indexed citations

18.

Nau, Marion M., et al.. (1988). Constitutive expression of multiple messenger rna forms of the c jun oncogene in human lung cancer cell lines. 29. 455. 10 indexed citations

19.

Krystal, Geoffrey W., Michael J. Birrer, James M. Way, et al.. (1988). Multiple Mechanisms for Transcriptional Regulation of the myc Gene Family in Small-Cell Lung Cancer. Molecular and Cellular Biology. 8(8). 3373–3381. 5 indexed citations

20.

Carney, Desmond N., Adi F. Gazdar, Marion M. Nau, & John D. Minna. (1985). Biological heterogeneity of small cell lung cancer.. PubMed. 12(3). 289–303. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact